Vertaling van "european region increased its contribution " (Nederlands → Frans) :

The European region increased its contribution to 44% of net sales (42% in 2007), while the rest of the world provided 25% (24% in 2007) of net sales.
La région Europe a augmenté sa contribution à 44% du chiffre d’affaires net (42% en 2007), alors que le reste du monde y a contribué pour 25% (24% en 2007).

EFSA - European Food Safety Authority. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.

Sandoz is increasing its pace of sales growth in 2010 on contributions from all regions and the integration of EBEWE Pharma coupled with a renewed focus on productivity, while Consumer Health aims to keep growing ahead of its markets after a successful start to the year.
Sandoz accélère en 2010 le rythme de progression de ses ventes grâce à des contributions de toutes les régions et à l’intégration d’EBEWE Pharma conjuguées à un centrage renouvelé sur la productivité.

Pharmaceuticals: USD 28.5 billion (+8%, +12% lc) All geographic regions and therapeutic areas contributed to the double-digit expansion in local currencies, driven by recently launched products (USD 4.7 billion, +81% lc) that increased their share of net sales to 16% in 2009 from 10% in 2008.
Pharmaceuticals: USD 28,5 milliards (+8%, +12% en m. l). Toutes les régions et tous les domaines thérapeutiques ont contribué à l’expansion à deux chiffres en monnaies locales, dopée par les produits lancés récemment (USD 4,7 milliards, +81% en m. l) qui ont augmenté leur part de chiffre d’affaires à 16% en 2009 contre 10% en 2008.